Vertex Pharmaceuticals

Vertex Pharmaceuticals reported strong financial performance for the fiscal year 2025, with revenue increasing by over 10% to reach $9.87 billion and net income rising to $3.62 billion. The company maintained a healthy profit margin of 36.7%, indicating efficient cost management.

• ·Revenue for the fiscal year was $9,869,200,000
• ·Net income reached $3,619,600,000
• ·Profit margin improved to 36.7%